Cargando…
The role of inflammation in ICU-acquired weakness
A pilot observational study by Weber-Carstens and colleagues contributes to a mechanistic explanation of the puzzling and complex phenomena of ICU-acquired weakness (ICU-AW). The authors suggest systemic, inflammatory-mediated pathology is the most significant risk factor for ICU-AW. While this find...
Autor principal: | Winkelman, Chris |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945106/ https://www.ncbi.nlm.nih.gov/pubmed/20727229 http://dx.doi.org/10.1186/cc9187 |
Ejemplares similares
-
ICU-acquired weakness
por: Vanhorebeek, Ilse, et al.
Publicado: (2020) -
Increased early systemic inflammation in patients with ICU-acquired weakness
por: Witteveen, E, et al.
Publicado: (2015) -
Weakness in the ICU: a call to action
por: Stevens, Robert D, et al.
Publicado: (2009) -
Causes of Mortality in ICU-Acquired Weakness
por: van Wagenberg, Linda, et al.
Publicado: (2017) -
0520. The role of mitochondrial dysfunction in the pathophysiology of icu-acquired weakness
por: Jiroutkova, K, et al.
Publicado: (2014)